Chemcrux Enterprises granted 107,700 stock options to eligible employees under its ESOP 2025 scheme.
The options vest 100% after one year and can be exercised within three years from vesting.
The grant was approved by the Nomination and Remuneration Committee on May 14, 2026.
Exercise price is set at ₹10 per option, with potential issuance of 107,700 new equity shares.